Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
Clinical trial NCT00740636 · COMPLETED
Trial details
- NCT number
- NCT00740636
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2013-02-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.